The purpose of this study is to test a potential treatment for atrial fibrillation, the most common type of heart arrhythmia (abnormal heart rhythm) requiring medical care. If successful, this medication could offer a more efficient treatment option than those currently available.
Therefore, the goal of this study is to give these two medications together to understand their interaction.
This clinical trial has been approved by an independent ethics committee and you will be reimbursed for your time.
Call us on 1800 243 733 to discuss your eligibility today!